Small interfering RNA (siRNA) Therapeutics- Competitive Landscape, Technology and Pipeline Insights

DelveInsight, the leading market research and consulting company has added a new report “Small interfering RNA (siRNA) Therapeutics- Competitive Landscape, Technology and Pipeline Insights, 2015” to its portfolio.
By: DelveInsight Business Research
 
DWARKA, India - Nov. 10, 2015 - PRLog -- The Small interfering RNA (siRNA) Therapeutics- Competitive Landscape, Technology and Pipeline Insights, 2015 report provides the client with details on the ongoing enterprises and the upcoming business opportunities related to new interventions. It comprehensively includes:

· 70+ pipeline drugs with 19+ companies actively involved in drug development. There are 2 drugs in phase III, 1 in phase II/III, 9 in phase II, 4 in phase I/II, 8 in phase I, 31 in pre-clinical, 12 in discovery, 3 in inactive  and 4 in discontinued.

· Alnylam Pharmaceuticals is developing a lead product ALN-TTR02 which is in Phase III.

· R&D activities and technologies used along with the pipeline molecules in development.

· Therapeutic assessments by molecule types, route of administration, monotherapy and combination products.

· Information related to collaborations, in-licensing and out-licensing deals.

DelveInsights, Small interfering RNA (siRNA) Therapeutics- Competitive Landscape, Technology and Pipeline Insights, 2015report provides the in-depth analysis of Small interfering RNA (siRNA) Therapeutics Competitive Landscape across the globe. Therefore the report on Small interfering RNA (siRNA) Therapeutics- Competitive Landscape, Technology and Pipeline Insights provides information on chemical, technology information and comparative analysis at various stages. In addition, it helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

DelveInsight is offering the Report at a price of USD 2250 as a single user license, USD 4500 as a site license and USD 6500 as a Global/Enterprise License.

For more information on Small interfering RNA (siRNA) Therapeutics- Competitive Landscape, Technology and Pipeline Insights 2015 report, email at info@delveInsight.com

Contact Us:

DelveInsight Business Research

New Delhi-110075, India

Phone: +91-11-45689769, +91 9650213330

Website: http://delveinsight.com

About Us

DelveInsight is a leading Business Consulting and Market Research Firm. They help clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. In addition to this DelveInsight also deals in providing custom research services in coherence with interest area of the clients.

Media Contact
DelveInsight Business Research
***@delveinsight.com
+91-11-45689769, +91 9650213330
End
Source:DelveInsight Business Research
Email:***@delveinsight.com Email Verified
Tags:DelveInsight, Interfering, Competitive
Industry:Business
Location:Dwarka - Delhi - India
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
DelveInsight PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share